Company Krebs Biochemicals & Industries Limited

KREBSBIO

INE268B01013

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sector Generic Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:49 2024-05-09 am EDT			5-day change	1st Jan Change
69.03 ^INR	-2.71%		-3.25%	-11.88%

Apr. 15	Krebs Biochemicals & Industries Limited Announces Resignation of Keyur Doshi as Company Secretary, Compliance Officer	CI
Feb. 12	Krebs Biochemicals & Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Krebs Biochemicals & Industries Ltd is an India-based company, which is engaged in the business of manufacture of active pharmaceutical ingredients. The Company manufactures bulk active pharmaceutical ingredients, pharmaceutical intermediates, fine chemicals, nutraceuticals utilizing two revenue streams: contract manufacturing for large pharmaceutical and multinational companies, and development of its products for sale in global markets. Its products include Androstenedione, Lovastatin, and Simvastatin. The Companyâs pilot or research and development stages products are Amlodipine, Cetirizine, Orlistat, Serratiopepetidase, Telmisartan, and Phenylephrine. The Company has two manufacturing facilities one at Regadichelaka, Nellore District and another one at Kothapalli Village, Kasimkota Mandal, Visakhapatnam District, Andhra Pradesh, India.

Number of employees: 210

INR in Million	2022	Weight	2023	Weight	Delta
Active Pharmaceutical Ingredients 100.0 %	529	100.0 %	521	100.0 %	-1.52%

INR in Million	2022	Weight	2023	Weight	Delta
India 100.0 %	529	100.0 %	521	100.0 %	-1.52%

Managers	Title	Age	Since
Jitendra Shah CEO	Chief Executive Officer	-	21-11-08
Ravindranath Tagore Ravi FOU	Founder	74	91-12-01
Ritesh Jain DFI	Director of Finance/CFO	-	23-02-02
Pabitrakumar Kalipada Bhattacharyya BRD	Director/Board Member	55	-
Avinash Ravi BRD	Director/Board Member	45	01-12-31
Sudhir Manne PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Gundapaneni Venkata Prasad BRD	Director/Board Member	67	00-09-25
Ravindranath Tagore Ravi FOU	Founder	74	91-12-01
Avinash Ravi BRD	Director/Board Member	45	01-12-31
Raj Kamal Prasad Verma BRD	Director/Board Member	75	16-02-11
Malati Tangirala BRD	Director/Board Member	74	13-12-31
Satish khemchand Khivsara BRD	Director/Board Member	78	15-09-28
Pabitrakumar Kalipada Bhattacharyya BRD	Director/Board Member	55	-
Jitendra Shah CEO	Chief Executive Officer	-	21-11-08

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	21,560,000	4,839,509 ( 22.45 %)	0	22.45 %

Krebs Biochemicals & Industries Ltd.

Plot No.34, 8-2-577/B 3rd Floor, Maas Heights

500034, Hyderabad

http://krebsbiochem.com

address Krebs Biochemicals & Industries Limited(KREBSBIO)

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Generic Pharmaceuticals

	1st Jan change	Capi.
KREBS BIOCHEMICALS & INDUSTRIES LIMITED	-11.88%	18.33M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+18.67%	43.74B
OTSUKA HOLDINGS CO., LTD.	+21.99%	22.26B
SANDOZ GROUP AG	+16.41%	14.9B
CIPLA LIMITED	+9.03%	13.39B
ZYDUS LIFESCIENCES LIMITED	+40.48%	12.12B
ONO PHARMACEUTICAL CO., LTD.	-9.64%	6.92B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+13.13%	5.47B

Generic Pharmaceuticals